Other languages Johnson & Johnson Berne S.E.

Equities

000943981

US4781601046

End-of-day quote Berne S.E. Other stock markets 06:00:00 2024-06-04 pm EDT			5-day change	1st Jan Change
132.3 ^CHF	+1.20%		+0.22%	+0.68%

11:20am	Citigroup Adjusts Price Target on Johnson & Johnson to $180 From $185, Keeps Buy Rating	MT
Jun. 05	J&J: applies to FDA for expanded indication for Prezcobix	CF

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Borsa di Italia: Verso l'infinito e oltre	02:00am
Bolsa de Madrid: Hasta el infinito y más allá	02:00am
J&J : sollicite la FDA une indiation élargie du Prezcobix	Jun. 05
J&J : essai concluant pour Carvykti dans le myélome multiple	Jun. 04
J&J : essai prometteur pour Tecvayli dans le myélome multiple	Jun. 04
Johnson & Johnson Ordered to Pay $260 Million In Talc Powder Case	Jun. 04
Borsa di Italia: Mai contenti!	Jun. 04
J&J must pay $260 million in latest talc trial, Oregon jury says	Jun. 03
Legend Biotech Says Phase 2 Trial of Carvykti to Treat Multiple Myeloma Showed 'Deep, Durable' Responses	Jun. 03
Johnson & Johnson Announces Results from a Subgroup Analysis of the Phase 3 CARTITUDE-4 Study	Jun. 03
Johnson & Johnson Announces Data from the Phase 3 PERSEUS Study	Jun. 03
Johnson & Johnson Announces New Data from the Phase 2 PALOMA-2 Study Evaluating Subcutaneous (SC) Amivantamab Combined with Lazertinib as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer	Jun. 03
Johnson & Johnson Announces Longer-Term Data from the Pivotal Phase 1/2 Majestec-1 Study of TECVAYLI	Jun. 03
J&J-backed Rapport Therapeutics seeks about $637 mln valuation in US IPO	Jun. 03
J&J-backed Rapport Therapeutics seeks to raise $144 mln in US IPO	Jun. 03
GSK blood cancer drug nearly halves risk of death in late-stage trial	Jun. 02
US lawmakers ask FBI for briefing on GenScript Biotech's links to China	Jun. 01
Johnson & Johnson Announces First Data from the Phase 3 PALOMA-3 Study Evaluating Subcutaneous (SC) Amivantamab Combined with Lazertinib	May. 31
Sector Update: Health Care Stocks Higher Late Afternoon	May. 31
US lawmakers ask FBI for briefing on GenScript Biotech's links to China	May. 31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST